🔴 BWX Technologies is trading 4.6% down today on mixed Q2 results and strategic pivot to core nuclear

BWX Technologies is trading at $166.00 (4.6% down) as investors weigh a Q2 revenue miss against a major strategic shift in the company's business model.

• The company beat non-GAAP EPS expectations and raised its full-year guidance, though it reported a modest revenue miss for the quarter.
• Management announced the sale of its medical business to refocus resources and capital on its core nuclear operations.
• The downward move reflects mixed market sentiment regarding the revenue shortfall and the divestiture of the medical segment.